Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM · BSE: 507789 · Pharmaceuticals & Biotechnology · 45 announcements

Share price
₹235.40
Market cap
₹1,553 Cr
Revenue (annual)
₹287.2 Cr
Net profit (annual)
₹43.08 Cr
P/E (TTM)
34.1×Sector 47.3×
Promoter holding
69.05%+1.16% QoQ
FII holding
2.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:39 IST BSE
Other Announcement

Jagsonpal Pharmaceuticals Other Announcement

The company informed shareholders without registered email addresses of the web-link to access the 2025-26 Annual Report and AGM Notice, per Regulation 36(1)(b).

15:10 IST BSE
Other Announcement

Jagsonpal Pharmaceuticals Other Announcement

Jagsonpal Pharmaceuticals filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The auditor reported nil non-compliances and no regulatory fines.

Execution
FY ended March 31, 2026